Literature DB >> 8118624

Evaluation of peak expiratory flow variability in an adolescent population sample. The Odense Schoolchild Study.

H C Siersted1, H S Hansen, N C Hansen, N Hyldebrandt, G Mostgaard, H Oxhøj.   

Abstract

The validity of peak expiratory flow (PEF) recordings and the sensitivity of PEF variability indices in asthma and asthma-like conditions were examined in an adolescent population. Recordings from 245 randomly selected subjects and from an additional 181 subjects reporting or considered at risk for developing asthma were analyzed. Subjects recorded PEF twice daily for 2 wk using Mini-Wright meters, completed a symptoms questionnaire, and were tested for airway responsiveness to methacholine. The first three recording days showed significant accumulation of lowest PEF values recorded (41%) and were excluded from further analysis. Among nine PEF variability indices, the Two-lowest%mean (the mean of the two lowest PEF values as a percentage of the period mean) had the best sensitivity for physician-diagnosed asthma (28%). The sensitivity of the methacholine dose-response slope (DRS) was 69%. Combining these indices, a sensitivity of 77% for diagnosed asthma was obtained. Among subjects with asthma-like symptoms but no diagnosis of asthma, 14% had increased Two-lowest%mean and the DRS was increased in 17%, but only 3% were identified by both tests. In conclusion, inhomogeneity of PEF data could be corrected by disregarding the first three recording days. PEF variability indices identified some diagnosed asthmatics, and particularly some symptomatic "nonasthmatics," not identified by the DRS, suggesting that the combined use of these indices might be helpful.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8118624     DOI: 10.1164/ajrccm.149.3.8118624

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  11 in total

1.  Diurnal variability--time to change asthma guidelines?

Authors:  H Reddel; C Jenkins; A Woolcock
Journal:  BMJ       Date:  1999-07-03

2.  Effects of volatile organic compounds, damp, and other environmental exposures in the home on wheezing illness in children.

Authors:  A J Venn; M Cooper; M Antoniak; C Laughlin; J Britton; S A Lewis
Journal:  Thorax       Date:  2003-11       Impact factor: 9.139

3.  Clinicians should be proactive in testing for asthma.

Authors:  A J Wardlaw; I D Pavord
Journal:  BMJ       Date:  1999-01-23

4.  Interrelationships between diagnosed asthma, asthma-like symptoms, and abnormal airway behaviour in adolescence: the Odense Schoolchild Study.

Authors:  H C Siersted; G Mostgaard; N Hyldebrandt; H S Hansen; J Boldsen; H Oxhøj
Journal:  Thorax       Date:  1996-05       Impact factor: 9.139

5.  Peak flow variability, methacholine responsiveness and atopy as markers for detecting different wheezing phenotypes in childhood.

Authors:  R T Stein; C J Holberg; W J Morgan; A L Wright; E Lombardi; L Taussig; F D Martinez
Journal:  Thorax       Date:  1997-11       Impact factor: 9.139

6.  Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long-term treatment with inhaled corticosteroids. Dutch CNSLD Study Group.

Authors:  P L Brand; E J Duiverman; H J Waalkens; E E van Essen-Zandvliet; K F Kerrebijn
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

7.  Asymptomatic bronchial hyperresponsiveness to exercise in childhood and the development of asthma related symptoms in young adulthood: the Odense Schoolchild Study.

Authors:  F Rasmussen; J Lambrechtsen; H C Siersted; H S Hansen; N C Hansen
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

8.  Variability of peak expiratory flow rate in children: short and long term reproducibility.

Authors:  T Frischer; R Meinert; R Urbanek; J Kuehr
Journal:  Thorax       Date:  1995-01       Impact factor: 9.139

9.  Safety of hookworm infection in individuals with measurable airway responsiveness: a randomized placebo-controlled feasibility study.

Authors:  J Feary; A Venn; A Brown; D Hooi; F H Falcone; K Mortimer; D I Pritchard; J Britton
Journal:  Clin Exp Allergy       Date:  2009-04-20       Impact factor: 5.018

10.  Experimental hookworm infection: a randomized placebo-controlled trial in asthma.

Authors:  J R Feary; A J Venn; K Mortimer; A P Brown; D Hooi; F H Falcone; D I Pritchard; J R Britton
Journal:  Clin Exp Allergy       Date:  2009-12-16       Impact factor: 5.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.